Serum Free Light Change in Multiple Myeloma
Serum Free Light Chain Ratio, Total Kappa/Lambda Ratio, and Immunofixation as Prognostic Factors in Multiple Myeloma.
1 other identifier
observational
N/A
1 country
1
Brief Summary
The purpose of this study is to evaluate the predictive role of free Kappa/Lambda ration in Multiple Myeloma post-transplant.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 28, 2009
CompletedFirst Posted
Study publicly available on registry
May 29, 2009
CompletedMay 29, 2009
May 1, 2009
May 28, 2009
May 28, 2009
Conditions
Keywords
Eligibility Criteria
A cohort of patients undergoing autolog transplantatio
You may qualify if:
- Patients affected with Multiple Myeloma who underwent autologous or auto/allogenic stem cell transplantation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azienda Ospedaliera S. Giovanni Battista
Torino, Torino, 10126, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 28, 2009
First Posted
May 29, 2009
Last Updated
May 29, 2009
Record last verified: 2009-05